Search for: "Hyman Phelps McNamara"
Results 101 - 120
of 232
Sorted by Relevance
|
Sort by Date
11 Dec 2024, 2:17 am
On Wednesday, December 11, Hyman, Phelps & McNamara, P.C. [read post]
9 Dec 2024, 9:02 pm
On Wednesday, December 11, Hyman, Phelps & McNamara, P.C. [read post]
8 Oct 2007, 9:58 pm
Hyman, Phelps & McNamara, P.C. submitted a letter on behalf of an unnamed company that has a tentatively approved ANDA for ramipril capsules. [read post]
31 Mar 2025, 7:35 pm
Laposata were represented by a team at Hyman, Phelps & McNamara, P.C., including Directors Michael Shumsky, Jeff Gibbs, Allyson Mullen, and Sara Koblitz, and Associates Steven Gonzalez and Sarah Wicks. [read post]
4 Sep 2024, 6:10 pm
Hyman, Phelps & McNamara, P.C. [read post]
15 Nov 2023, 1:57 am
Hyman, Phelps & McNamara, P.C. [read post]
16 Apr 2025, 8:26 pm
Claud —Hyman, Phelps & McNamara, P.C. is hosting a free webinar on recent and forward-looking enforcement under the Federal Food, Drug & Cosmetic Act on Thursday, May 1, 2025, from 12:00 p.m. to 1:30 p.m. [read post]
5 Jan 2022, 12:00 am
Hyman, Phelps & McNamara, P.C. [read post]
31 May 2022, 7:33 pm
Hyman, Phelps & McNamara, P.C. [read post]
29 Oct 2009, 9:40 am
” The webinar will feature: FDA regulatory lawyer Ricardo Carvajal from Hyman, Phelps & McNamara; Roberta Anderson from Food Alliance, the nation’s leader in setting third-party sustainability standards for food production; Alison Dennis from Burgerville, a traditional quick-service restaurant on the cutting edge of sustainability; and Advertising lawyer Jere Webb from Stoel Rives. [read post]
22 Jan 2023, 9:08 pm
As we have done in the past for significant laws amending the operative food and drug statutes, Hyman, Phelps & McNamara, P.C. has prepared a detailed Summary and Analysis of FDORA. [read post]
23 May 2022, 5:59 am
Hyman, Phelps, and McNamara’s Sara Koblitz will be presenting at the DC Bar’s annual webinar, “FDA for IP Lawyers” on May 25, 2022 with Brian Malkin of McDermott, Will, and Emery. [read post]
12 Jun 2024, 6:21 pm
Sasinowski —Hyman, Phelps & McNamara (HPM) would like to congratulate the 7 rare disease programs selected for the inaugural class of the FDA’s “Support for clinical Trials Advancing Rare disease Treatment” (START) pilot program. [read post]
13 Nov 2023, 3:15 am
Program highlights include: Spotlight on FDA’s Newly Proposed ACNU Rule Updates on Monograph Reform Implementation Advertising, Labeling and Claims Substantiation Essentials Exploring the Recent Wave of Rx-OTC Drug Switches Hyman, Phelps & McNamara, P.C. [read post]
4 May 2022, 8:26 pm
Hyman, Phelps & McNamara, P.C. is pleased to announce that Sophia Gaulkin will be speaking on an expert panel at the 20th Advanced Summit on Life Sciences Patents, which is being held virtually and in-person in New York City on June 2-3, 2022. [read post]
19 Mar 2023, 4:38 pm
Hyman, Phelps & McNamara, P.C. [read post]
19 May 2024, 5:49 pm
Joni Rutter, Director of the National Center for Advancing Translational Sciences, and Hyman, Phelps & McNamara’s own Frank Sasinowski who also serves as the Vice Chair of the Board for ELF. [read post]
14 Jun 2011, 5:40 am
Hyman, Phelps & McNamara, P.C.'s Jeffrey K. [read post]
14 Apr 2022, 10:49 am
Over the course of two days, this event will provide impactful and practical programming all geared towards assessing the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent endgame and the pursuit of related profits. 2022 agenda highlights include: The Viability of Written Description as a Compelling Invalidity Defense Clarity On What Satisfies Section 1400(b)’s Venue Requirements in the Hatch-Waxman Context Whether a Skinny Label… [read post]
12 Jun 2024, 2:26 am
Hyman, Phelps & McNamara, P.C. [read post]
